Neuronal dysfunction in Refractory Chronic Cough

People with chronic refractory cough feel a persistent urge to cough that standard treatments cannot stop, and researchers now suspect that a molecule called adenosine triphosphate (ATP) is driving this hypersensitivity in the brain and airways. This matters because chronic refractory cough affects a significant number of people, yet its underlying mechanisms remain poorly understood. Current treatments often fail because they target general inflammation or airway constriction rather than the specific neuronal pathways involved. The key gap is knowing how ATP—normally an energy source inside cells—triggers cough when released into the airways and acts on the central nervous system. If this research succeeds, it could identify ATP and its breakdown products as measurable markers of cough severity, and reveal the specific sensations and triggers that provoke coughing. That would allow clinicians to diagnose the condition more precisely and open the door to drugs that block ATP signalling—treatments that target the root cause rather than just symptoms. For patients, this could mean a shift from trial-and-error therapies to a rational, mechanism-based approach that actually stops the cough.